| Name | Tumulosic acid |
|---|---|
| Synonyms |
3β,16α-dihydroxy-eburica-8,24(28)-dien-21-oic acid
3β,16α-Dihydroxy-eburica-8,24(28)-dien-21-saeure 3β.16α-Dihydroxy-24-methylen-lanosten-(8)-saeure-(21) Tumulosaeure Tumulossaeure |
| Description | Tumulosic acid, a triterpenoid, inhibits KLK5 protease activity (IC50= 14.84 μM). Tumulosic acid suppresses the proteolytic processing of LL-37 in keratinocytes at ≤10 μM[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Tumulosic acid displays dose-dependent anti-KLK5 activity (IC50=19.3 μM)[1]. Tumulosic acid decreases in LL-37 production in human keratinocytes[1]. Tumulosic acid shows IC50 values of 14.84 and 10.48 μM against KLK5 and trypsin proteases, while it exhibited a weak inhibitory effect on KLK7 and chymotrypsin C proteases (19.5% and 4.0%, respectively, at 100 μM)[1]. Western Blot Analysis[1] Cell Line: Normal human epidermal keratinocytes (NHEKs) Concentration: 1 μM and 10 μM Incubation Time: 23 h in the presence of 10 μM cycloheximide Result: Decreased LL-37 production in epidermal keratinocytes. |
| References |
| Molecular Formula | C31H50O4 |
|---|---|
| Molecular Weight | 486.72600 |
| Exact Mass | 486.37100 |
| PSA | 77.76000 |
| LogP | 6.76060 |
| Storage condition | 2-8℃ |